NCT03597438View on ClinicalTrials.gov

National CounterACT Initiative

CompletedOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

April 18, 2023

Study Completion Date

February 22, 2024

Conditions
Mitochondrial Alteration
Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT03597438 - National CounterACT Initiative | Biotech Hunter | Biotech Hunter